Journal of Infectious Diseases & Preventive Medicine
Open Access

Overview on the Detailed Study on Ebola Virus Disease

Adejimi Adeniji^{* *}Correspondence: Adejimi Adeniji, Department of Infectious Diseases, Tshwane University of Technology, Pretoria, South Africa, Email:

Author info »

Description

Ebola Virus Disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe and often deadly illness caused by infection with one of the Ebola virus strains. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. First identified in 1976 during simultaneous outbreaks in Sudan and the Democratic Republic of Congo (DRC), Ebola virus outbreaks have since occurred sporadically in Central and West Africa, with the largest outbreak recorded in West Africa from 2014 to 2016.

Causes and transmission

Ebola virus disease is caused by infection with the Ebola virus, which belongs to the family Filoviridae, genus Ebolavirus. The virus is zoonotic, meaning it is transmitted to humans from infected wild animals, often through contact with their bodily fluids or consumption of contaminated bushmeat. Fruit bats of the Pteropodidae family are considered natural hosts of the Ebola virus.

Once introduced into the human population, Ebola virus spreads through human-to-human transmission via direct contact with bodily fluids (such as blood, saliva, urine, feces, vomit, semen) of infected individuals. Transmission can occur through broken skin or mucous membranes.

Diagnosis

Diagnosing Ebola virus disease can be challenging due to its nonspecific early symptoms, which resemble other infectious diseases such as malaria, typhoid fever, and other viral hemorrhagic fevers.

Healthcare providers assess symptoms and potential exposure history (travel to endemic areas, contact with infected individuals). Early diagnosis is crucial for patient management and outbreak control. Detects viral RNA in blood or other body fluids.

Treatment

Fluid and electrolyte management: Intravenous fluids and electrolytes are administered to maintain hydration and electrolyte balance, especially in patients with severe vomiting and diarrhea.

Experimental treatments: During outbreaks, experimental treatments such as monoclonal antibodies, antiviral drugs, and convalescent plasma from recovered patients may be considered under strict clinical protocols.

Infection control measures: Strict infection control practices, including isolation of patients and proper Personal Protective Equipment (PPE) for healthcare workers, are essential to prevent further spread of the virus.

Prevention

Public health measures: Rapid identification and isolation of suspected cases, contact tracing, and quarantine of contacts are essential for outbreak control.

Safe burial practices: Traditional burial practices involving direct contact with the deceased can contribute to the spread of Ebola virus. Safe burial practices that minimize contact with bodily fluids are critical.

Personal Protective Equipment (PPE): Healthcare workers and those caring for sick individuals must use appropriate PPE, including gloves, masks, goggles, and gowns, to prevent exposure to bodily fluids.

Vaccine: An Ebola virus vaccine (rVSV-ZEBOV) has been shown to be effective in preventing the disease during outbreaks. Vaccination campaigns target frontline healthcare workers and contacts of confirmed cases.

Research and global response

Ongoing research focuses on developing effective vaccines, antiviral drugs, and improving diagnostic tools for Ebola virus disease. International organizations such as the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and Médecins Sans Frontières (MSF) play essential roles in outbreak response, providing technical assistance, logistics support, and healthcare worker training.

Conclusion

Ebola virus disease remains a significant global health challenge due to its high fatality rate, potential for outbreaks, and the severe socioeconomic impact on affected communities. Understanding the transmission dynamics, early detection, supportive care, and preventive measures are critical for controlling outbreaks and reducing the burden of this deadly disease. Continued research, international collaboration, and strengthened healthcare systems are essential for effective preparedness and response to future Ebola virus outbreaks.